Trial register facet
Reported trial records — page 26
644 records with the status reported.
Showing 0 records on this page
Records
644 documents · page 26 of 27
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| HEX-PH1-GH | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Low |
| GHRP6-PH1-GH | GHRP-6 | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Low |
| HEX-PH1-GH-DDIprogramme record | Hexarelin | Phase 1 | Reported | Randomised crossover | — | 1995 | Very low |
| GHRP6-PH1-GH-OLEprogramme record | GHRP-6 | Phase 1 | Reported | Single-arm open-label | — | 1995 | Very low |
| HEX-PH1-GH-HEPATIC-IMPprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| GHRP6-PH1-GH-ELDERLYprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| HEX-PH1-GH-RENAL-IMPprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| GHRP6-PH1-GH-BIOMARKERprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| HEX-PH1-GH-PKprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| GHRP6-PH1-GH-ADHERENCEprogramme record | GHRP-6 | Phase 1 | Reported | Observational | — | 1995 | Very low |
| HEX-PH1-GH-OLEprogramme record | Hexarelin | Phase 1 | Reported | Single-arm open-label | — | 1995 | Very low |
| GHRP6-PH1-GH-QOLprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| AMY-PH1-ORALprogramme record | Cagrilintide | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| AMY-PH1B-SCprogramme record | Cagrilintide | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| GNRH-DIAGNOSTIC | Gonadorelin | — | Reported | Diagnostic accuracy | — | — | Moderate |
| GNRH-PULSATILE-HH | Gonadorelin | — | Reported | Single-arm open-label | — | — | Moderate |
| SERM-DIAGNOSTIC | Sermorelin | — | Reported | Diagnostic accuracy | — | — | Moderate |
| EPI-RU-ELDERLY-PKprogramme record | Epithalon | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| BPC-PH2-UC-REGIONAL-JPprogramme record | BPC-157 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| THYMALIN-RU-1-ELDERLYprogramme record | Thymalin | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SEMAX-RU-COGNITIVE-QOLprogramme record | Semax | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SEMAX-RU-STROKE-OLEprogramme record | Semax | — | Reported | Single-arm open-label | — | — | Very low |
| SELANK-RU-ANXIETY-DDIprogramme record | Selank | Phase 1 | Reported | Randomised crossover | — | — | Very low |
| GNRH-DIAGNOSTIC-REGIONAL-JPprogramme record | Gonadorelin | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
page 26 of 27